General Diagnostic Procedures
Please Note: The
technologies listed here are not available to the public at this time.
These technologies are in the early stages of research and require further
development before they are ready for the marketplace. The VA is currently
in the process of identifying potential companies who may be interested in
licensing and/or further developing the technology through Cooperative Research
and Development Agreements (CRADA).
Through cooperative research initiatives such as these, it is our hope and
goal that commercial products will be fully developed and made available
to benefit veterans and others.
|
Date Posted |
Reference No. |
Patent No. |
Title |
07/10/2006 |
06-096 |
7,550,299 |
Oxidative Stress Markers Predict Atrial Fibrillation |
05/18/2005 |
04-200 |
7,279,281 7,439,024 |
PCR Identification of Lupus Biomarkers |
02/17/2005 |
04-119 |
7,429,482 |
Screening Tools for Discovery of Novel Anabolic Agents |
03/29/2004 |
03-079 |
|
Macrophage Migration Inhibitory Factor: A Novel Diagnostic for Urological Inflammatory Disease and Cancer |
05/30/2003 |
03-044 |
7,361,474 |
Diagnosis and Monitoring of Prostate Cancer Patients by Measurement of Serum Macrophage Migration Inhibitory Factor. |
07/26/2004 |
02-030 |
|
Engineered Stem Cells Delivered Directly into Digestive Organs for Drug Delivery, Gene Therapy, Cell Replacement, Research and Diagnostic Applications |
|
|
Reviewed/Updated Date: November 13, 2006 |
|